Skip to Content Skip to Content

Cancer Research

A serendipitous find leads to lifesaving discoveries
Fluorescent imaging of glioblastoma under a microscope.

Image: Kyosuke Shishikura

A serendipitous find leads to lifesaving discoveries

A Penn-led team has revealed a how hydralazine, one of the world’s oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a surprising discovery—it can also halt the growth of aggressive brain tumors.

3 min. read

2025 Basser Center Awards

2025 Basser Center Awards

The Basser Center for BRCA at the Abramson Cancer Center has announced two awards for 2025. Ephrat Levy-Lahad of Shaare Zedek Medical Center and the Hebrew University of Jerusalem is the recipient of the 2025 Basser Global Prize for her BRCA1 and BRCA2-related research. Alan D. D’Andrea of the Dana-Farber Cancer Institute is awarded the 2025 BRCA Impact Award for his research in in cancer genetics.

Tumor-on-a-chip offers insight into cancer-fighting cells in immunotherapy
Hand holding a microdevice

Penn engineers and collaborators have developed a transparent, micro-engineered device that houses a living, vascularized model of human lung cancer—a “tumor on a chip”—and show that the diabetes drug vildagliptin helps more CAR T cells break through the tumor’s defenses and attack it effectively.

(Image: Courtesy of Dan Huh)

Tumor-on-a-chip offers insight into cancer-fighting cells in immunotherapy

Penn engineers and collaborators have built a living tumor on a chip to expose how cancers block immune attacks, and how one existing drug could make immunotherapy like CAR T more effective against solid tumors.

3 min. read